These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9577645)

  • 1. [Polyclonal plasmacytosis in peripheral blood and leukocytoclastic vasculitis in Castleman's disease].
    Izutsu K; Usuki K; Inoue K; Endo M; Iki S; Matsuya S; Urabe A
    Rinsho Ketsueki; 1998 Mar; 39(3):210-5. PubMed ID: 9577645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudo-myelomatous plasmacytosis of the bone marrow in a multicentric Castleman's disease].
    Molina T; Brouland JP; Bigorgne C; Le Tourneau A; Delmer A; Audouin J; Diebold J
    Ann Pathol; 1996; 16(2):133-6. PubMed ID: 8767683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are multicentric Castleman's disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity?
    Kayasut K; Le Tourneau A; Rio B; Bost-Bezeaud F; Heuberger L; Diebold J; Audouin J
    Histopathology; 2006 Nov; 49(5):557-8. PubMed ID: 17064311
    [No Abstract]   [Full Text] [Related]  

  • 4. Castleman's disease with renal infiltration by polyclonal plasma cells.
    Frøkjaer Thomsen O; Ladefoged J
    Clin Nephrol; 1998 May; 49(5):328-30. PubMed ID: 9617500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
    Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
    Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric Castleman disease with cutaneous manifestations: report of 2 cases and comparison with systemic plasmacytosis.
    Higashi Y; Kanekura T; Sakamoto R; Mochitomi Y; Kanzaki T
    Dermatology; 2007; 214(2):170-3. PubMed ID: 17341868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological study of a case of systemic angiofollicular hyperplasia (Castleman's disease).
    Rais M; Ferreli F; Avataneo MC; Murgia A; Pili P; Nicolosi A; Massidda B
    Pathologica; 1990; 82(1077):89-94. PubMed ID: 2362788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric plasma cell variant Castleman's disease presenting with cutaneous vasculitis and pulmonary parenchymal involvement in a patient with ankylosing spondylitis: case report and review of the literature.
    Wolf M; Van Offel JF; Van de Velde A; Stevens WJ; De Clerck LS
    Acta Clin Belg; 2011; 66(4):305-10. PubMed ID: 21938988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus and Castleman's disease.
    Suwannaroj S; Elkins SL; McMurray RW
    J Rheumatol; 1999 Jun; 26(6):1400-3. PubMed ID: 10381064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaline-vascular type of Castleman's disease (angiofollicular lymph node hyperplasia) with monotypic plasma cells. An immunohistochemical study with monoclonal antibodies.
    Chilosi M; Menestrina F; Lestani M; Bonetti F; Scarpa A; Caligaris-Cappio F; Pizzolo G; Perini A; Fiore-Donati L
    Histol Histopathol; 1987 Jan; 2(1):49-55. PubMed ID: 2980702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case of malignant lymphoma associated with primary systemic plasmacytosis with polyclonal hypergammaglobulinemia.
    Nitta Y
    Am J Dermatopathol; 1997 Jun; 19(3):289-93. PubMed ID: 9185918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Castleman's disease, intermediate type: a case report.
    Raphael V; Lyngdoh RH
    Indian J Pathol Microbiol; 2006 Oct; 49(4):603-4. PubMed ID: 17183872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous CD5+ marginal zone B-cell lymphoma resembling the plasma cell variant of Castleman's disease. Case report.
    Tsukamoto N; Kojima M; Uchiyama T; Takeuchi T; Karasawa M; Murakami H; Sato S
    APMIS; 2007 Dec; 115(12):1426-31. PubMed ID: 18184415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant lymph node hyperplasia (Castleman's disease) of the parotid region--a case report.
    Prasad HS; Sankaran V; Raman ML; Veliath AJ; Ananthakrishnan N
    Indian J Pathol Microbiol; 1988 Apr; 31(2):68-70. PubMed ID: 3169920
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia: a report of 16 cases.
    Kojima M; Nakamura S; Shimizu K; Itoh H; Yamane Y; Murayama K; Tanaka H; Sugihara S; Shimano S; Sakata N; Masawa N
    Int J Surg Pathol; 2004 Jan; 12(1):25-30. PubMed ID: 14765269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of multicentric Castleman's disease with pulmonary involvement].
    Morise M; Shimomoto H; Honda T; Mori Y
    Nihon Kokyuki Gakkai Zasshi; 2003 Jan; 41(1):59-65. PubMed ID: 12693008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indurated nodules and plaques showing a dense plasma cell infiltrate as a cutaneous manifestation of Castleman's disease.
    Okuyama R; Harigae H; Moriya T; Kagatani S; Tagami H; Ichinohasama R; Aiba S
    Br J Dermatol; 2007 Jan; 156(1):174-6. PubMed ID: 17199591
    [No Abstract]   [Full Text] [Related]  

  • 18. Extralymphonodal Castleman's disease. A case report.
    Malaguarnera M; Restuccia N; Laurino A; Lo Manto PC; Vinci E; Pistone G
    Panminerva Med; 1999 Dec; 41(4):363-6. PubMed ID: 10705721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual location for Castleman's disease.
    Rao HG; Street I; Capper R
    J Laryngol Otol; 2009 Jan; 123(1):e3. PubMed ID: 19046470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical systemic lupus erythematosus or Castleman's disease.
    Van de Voorde K; De Raeve H; De Block CE; Van Regenmortel N; Van Offel JF; De Clerck LS; Stevens WJ
    Acta Clin Belg; 2004; 59(3):161-4. PubMed ID: 15462513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.